We are now part of the European Alzheimer's Disease Consortium (EADC), a fully functional network of over 60 European Centres of Excellence working in the field of Alzheimer's Disease and related dementias research and care.
Our Annals of Neurology 2013 manuscript has been included between the 50 most influential Alzheimer's Disease research papers of the last five years.
Glad to share with you this brand new publication Co-Authored with Bengt Winblad! Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? JAD 2016
We are excited to share with you our brand new publication on the Validation of Clinico-Radiological Criteria for the Diagnosis of CAA-ri made in collaboration with our friends Steve's Group in Boston!
Thursday, November 5th at 4.45pm, we will present the latest iCAβ International Network Research Products at the CTAD 2015 Meeting in Barcelona, Spain.
ORAL COMMUNICATIONS SESSION: Hot topics in AD clinical trials
TITLE: CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAβ International Network.
We are very excited to discuss our results with worldwide leaders in the treatment of Alzheimer’s disease! CTAD2015 Program: http://www.ctad-alzheimer.com/program
April 2015. We are pleased to announce the recent establishment of the iCAβ-Italy SINdem Study Group, the Italian counterpart of the iCAβ International Network under the aegis of the Italian Society of Neurology for Dementia (SINdem). This recognition is a further proof of the quality of the work we are pursuing through our Network.
Friday, 27th March 2015, we will present the latest Network Research at the SINdem Meeting in Genova (Italy), with the contribution entitled: "Late recurrence of Cerebral Amyloid Angiopathyrelated inflammation: report from the iCAßItaly SINdem Study Group"